Search

Tony Michael Argenbright

Examiner (ID: 16324)

Most Active Art Unit
3402
Art Unit(s)
3402, 3747
Total Applications
2731
Issued Applications
2589
Pending Applications
40
Abandoned Applications
102

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6417857 [patent_doc_number] => 20100167326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'METHOD FOR CLEAVAGE OF PEPTIDIC BOND AT C TERMINAL OF PEPTIDE AND A METHOD FOR DETERMINATION OF C TERMINAL AMINO ACID SEQUENCE OF PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/278878 [patent_app_country] => US [patent_app_date] => 2007-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10310 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167326.pdf [firstpage_image] =>[orig_patent_app_number] => 12278878 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/278878
METHOD FOR CLEAVAGE OF PEPTIDIC BOND AT C TERMINAL OF PEPTIDE AND A METHOD FOR DETERMINATION OF C TERMINAL AMINO ACID SEQUENCE OF PEPTIDE Feb 7, 2007 Abandoned
Array ( [id] => 10857763 [patent_doc_number] => 08883965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 12/223654 [patent_app_country] => US [patent_app_date] => 2007-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3327 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12223654 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/223654
Compounds Feb 4, 2007 Issued
Array ( [id] => 5514778 [patent_doc_number] => 20090215085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Proteomic Fingerprinting of Human IVF-Derived Embryos: Identification of Biomarkers of Developmental Potential' [patent_app_type] => utility [patent_app_number] => 12/162471 [patent_app_country] => US [patent_app_date] => 2007-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15986 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215085.pdf [firstpage_image] =>[orig_patent_app_number] => 12162471 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/162471
Proteomic Fingerprinting of Human IVF-Derived Embryos: Identification of Biomarkers of Developmental Potential Jan 28, 2007 Abandoned
Array ( [id] => 5285403 [patent_doc_number] => 20090099078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Nogo Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/162256 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 65160 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099078.pdf [firstpage_image] =>[orig_patent_app_number] => 12162256 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/162256
Nogo receptor antagonists Jan 25, 2007 Issued
Array ( [id] => 4826829 [patent_doc_number] => 20080125373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'MNTF peptides and compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 11/657815 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10530 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125373.pdf [firstpage_image] =>[orig_patent_app_number] => 11657815 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/657815
MNTF peptides and compositions and methods of use Jan 24, 2007 Issued
Array ( [id] => 5367135 [patent_doc_number] => 20090304694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Ang2 and Vegf Inhibitor Combinations' [patent_app_type] => utility [patent_app_number] => 12/223003 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22843 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304694.pdf [firstpage_image] =>[orig_patent_app_number] => 12223003 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/223003
Ang2 and Vegf Inhibitor Combinations Jan 18, 2007 Abandoned
Array ( [id] => 111916 [patent_doc_number] => 07718617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Methods for preserving organs and tissues' [patent_app_type] => utility [patent_app_number] => 11/621246 [patent_app_country] => US [patent_app_date] => 2007-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11433 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718617.pdf [firstpage_image] =>[orig_patent_app_number] => 11621246 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/621246
Methods for preserving organs and tissues Jan 8, 2007 Issued
Array ( [id] => 5070173 [patent_doc_number] => 20070191275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments' [patent_app_type] => utility [patent_app_number] => 11/649889 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8229 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191275.pdf [firstpage_image] =>[orig_patent_app_number] => 11649889 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/649889
Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments Jan 4, 2007 Abandoned
Array ( [id] => 9944418 [patent_doc_number] => 08993719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => 'Methods and compositions related to mutant Kunitz domain I of TFPI-2' [patent_app_type] => utility [patent_app_number] => 12/087296 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 14481 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12087296 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/087296
Methods and compositions related to mutant Kunitz domain I of TFPI-2 Dec 28, 2006 Issued
Array ( [id] => 142396 [patent_doc_number] => 07691964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Peptide anti-tumor agent' [patent_app_type] => utility [patent_app_number] => 11/615723 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8624 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691964.pdf [firstpage_image] =>[orig_patent_app_number] => 11615723 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/615723
Peptide anti-tumor agent Dec 21, 2006 Issued
Array ( [id] => 5397310 [patent_doc_number] => 20090317373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Inhibition of the Anti-FVIII Immune Response' [patent_app_type] => utility [patent_app_number] => 12/086851 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 7238 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317373.pdf [firstpage_image] =>[orig_patent_app_number] => 12086851 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/086851
Inhibition of the Anti-FVIII Immune Response Dec 21, 2006 Abandoned
Array ( [id] => 6589670 [patent_doc_number] => 20100130432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Non-Natural Amino Acids and Neurotensin Analogues Thereof' [patent_app_type] => utility [patent_app_number] => 12/086528 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 42733 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130432.pdf [firstpage_image] =>[orig_patent_app_number] => 12086528 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/086528
Non-Natural Amino Acids and Neurotensin Analogues Thereof Dec 14, 2006 Abandoned
Array ( [id] => 5136461 [patent_doc_number] => 20070078090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'ANTI-CHRONDROSARCOMA COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/609816 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19627 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078090.pdf [firstpage_image] =>[orig_patent_app_number] => 11609816 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/609816
Anti-chrondrosarcoma compounds Dec 11, 2006 Issued
Array ( [id] => 5035282 [patent_doc_number] => 20070099821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => ' METHOD OF ACTIVATING INSULIN RECEPTOR SUBSTRATE-2 TO STIMULATE INSULIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 11/609530 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11046 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099821.pdf [firstpage_image] =>[orig_patent_app_number] => 11609530 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/609530
METHOD OF ACTIVATING INSULIN RECEPTOR SUBSTRATE-2 TO STIMULATE INSULIN PRODUCTION Dec 11, 2006 Abandoned
Array ( [id] => 7740558 [patent_doc_number] => 08106016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Compounds and compositions for prevention of overdose of oxycodone' [patent_app_type] => utility [patent_app_number] => 11/635788 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 12709 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106016.pdf [firstpage_image] =>[orig_patent_app_number] => 11635788 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/635788
Compounds and compositions for prevention of overdose of oxycodone Dec 7, 2006 Issued
Array ( [id] => 5219311 [patent_doc_number] => 20070160622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Method for assembling a polymer-biologic delivery composition' [patent_app_type] => utility [patent_app_number] => 11/636230 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31407 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160622.pdf [firstpage_image] =>[orig_patent_app_number] => 11636230 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/636230
Method for assembling a polymer-biologic delivery composition Dec 6, 2006 Abandoned
Array ( [id] => 5130715 [patent_doc_number] => 20070207112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Anti-acne composition' [patent_app_type] => utility [patent_app_number] => 11/634368 [patent_app_country] => US [patent_app_date] => 2006-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4086 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207112.pdf [firstpage_image] =>[orig_patent_app_number] => 11634368 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/634368
Anti-acne composition Dec 4, 2006 Abandoned
Array ( [id] => 5160404 [patent_doc_number] => 20070173448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'SOLUTION FOR REMOVING CATARACTS VIA LIQUEFRACTURE' [patent_app_type] => utility [patent_app_number] => 11/565256 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3885 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173448.pdf [firstpage_image] =>[orig_patent_app_number] => 11565256 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/565256
SOLUTION FOR REMOVING CATARACTS VIA LIQUEFRACTURE Nov 29, 2006 Abandoned
Array ( [id] => 5172370 [patent_doc_number] => 20070072803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level' [patent_app_type] => utility [patent_app_number] => 11/603410 [patent_app_country] => US [patent_app_date] => 2006-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77278 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072803.pdf [firstpage_image] =>[orig_patent_app_number] => 11603410 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/603410
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Nov 21, 2006 Issued
Array ( [id] => 5172371 [patent_doc_number] => 20070072804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level' [patent_app_type] => utility [patent_app_number] => 11/603417 [patent_app_country] => US [patent_app_date] => 2006-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77229 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072804.pdf [firstpage_image] =>[orig_patent_app_number] => 11603417 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/603417
Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Nov 21, 2006 Issued
Menu